로딩 중…
지수 로딩 중…
Relay Therapeutics, Inc.
RLAY· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$15.87+1.99%
2026-06-18
Price Chart
Relay Therapeutics, Inc.+372.32%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $3.40B |
| Revenue | $11M |
| Net Income | $-273M |
| Total Assets | $700M |
| Net Assets | $642M |
| Value | |
| P/B | 5.30x |
| P/S | 318.83x |
| FCF Yield | -6.27% |
| Profitability | |
| ROE | -42.47% |
| ROA | -38.98% |
| Op. Margin | -2776.61% |
| Revenue Growth | -60.93% |
| Financial Health | |
| Debt Ratio | 8.94% |
| Total Debt | $32M |
| FCF | $-213M |
| Cash | $205M |
| Current Ratio | 22.13x |
| Performance | |
| 1Y Return | 372.32% |
| 1M Return | 31.48% |
| From 52W High | -9.16% |
| 1Y MDD | -28.15% |
| Trading | |
| Volume | 7,468,919 shares |
| Trading Value | $120M |
| Per Share | |
| EPS | $-1.61 |
| BPS | $3.30 |